Yesterday, Nov. 4, 2015, 107 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $85.86 to $4,999,847.37.

Highlighted Stocks Traded by Insiders:

Northrim BanCorp (NRIM) - FREE Research Report

Schierhorn Joseph M, who is Evp, Coo at Northrim BanCorp, sold 2,600 shares at $28.53 on Nov. 4, 2015. Following this transaction, the Evp, Coo owned 17,614 shares meaning that the stake was reduced by 12.86% with the 2,600-share transaction.

The shares most recently traded at $28.54, up $0.01, or 0.04% since the insider transaction. Historical insider transactions for Northrim BanCorp go as follows:

  • 4-Week # shares bought: 251
  • 4-Week # shares sold: 1,142
  • 12-Week # shares bought: 1,801
  • 12-Week # shares sold: 1,942
  • 24-Week # shares bought: 8,713
  • 24-Week # shares sold: 1,942

The average volume for Northrim BanCorp has been 19,200 shares per day over the past 30 days. Northrim BanCorp has a market cap of $198.2 million and is part of the financial sector and banking industry. Shares are up 9.22% year-to-date as of the close of trading on Wednesday.

Northrim BanCorp, Inc. operates as bank holding company for Northrim Bank that provides commercial banking products and services to businesses and professional individuals primarily in Alaska. The company operates in two segments, Community Banking and Home Mortgage Lending. The stock currently has a dividend yield of 2.63%. The company has a P/E ratio of 9.8. Currently, there are no analysts who rate Northrim BanCorp a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on NRIM - FREE

TheStreet Quant Ratings

rates Northrim BanCorp as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income, notable return on equity, expanding profit margins and impressive record of earnings per share growth. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Northrim BanCorp Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

DigitalGlobe (DGI) - FREE Research Report

Comfort Stephanie, who is SVP, Strategy, Comms and Mktg at DigitalGlobe, bought 3,060 shares at $16.36 on Nov. 4, 2015. Following this transaction, the SVP, Strategy, Comms and Mktg owned 26,757 shares meaning that the stake was boosted by 12.91% with the 3,060-share transaction.

The shares most recently traded at $16.76, up $0.40, or 2.39% since the insider transaction. Historical insider transactions for DigitalGlobe go as follows:

  • 4-Week # shares bought: 25,100
  • 4-Week # shares sold: 3,482
  • 12-Week # shares bought: 25,100
  • 12-Week # shares sold: 3,482
  • 24-Week # shares bought: 28,400
  • 24-Week # shares sold: 3,482

The average volume for DigitalGlobe has been 680,300 shares per day over the past 30 days. DigitalGlobe has a market cap of $1.1 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are down 46.34% year-to-date as of the close of trading on Wednesday.

DigitalGlobe, Inc. provides imagery and imagery information products and services in the United States and internationally. The company has a P/E ratio of 58.3. Currently, there are 5 analysts who rate DigitalGlobe a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DGI - FREE

TheStreet Quant Ratings

rates DigitalGlobe as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and disappointing return on equity. Get the full

DigitalGlobe Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

AthenaHealth (ATHN) - FREE Research Report

Abernethy Amy, who is Director at AthenaHealth, sold 1,000 shares at $152.35 on Nov. 4, 2015. Following this transaction, the Director owned 2,949 shares meaning that the stake was reduced by 25.32% with the 1,000-share transaction.

The shares most recently traded at $162.15, up $9.80, or 6.04% since the insider transaction. Historical insider transactions for AthenaHealth go as follows:

  • 4-Week # shares sold: 7,000
  • 12-Week # shares sold: 15,759
  • 24-Week # shares sold: 19,259

The average volume for AthenaHealth has been 469,400 shares per day over the past 30 days. AthenaHealth has a market cap of $6.3 billion and is part of the technology sector and computer software & services industry. Shares are up 10.16% year-to-date as of the close of trading on Wednesday.

athenahealth, Inc., together with its subsidiaries, operates as a business services company that provides ongoing billing, clinical-related, and other related services to medical group practices and health systems in the United States. The company has a P/E ratio of 417.1. Currently, there are 11 analysts who rate AthenaHealth a buy, 2 analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ATHN - FREE

TheStreet Quant Ratings

rates AthenaHealth as a

hold

. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, robust revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including premium valuation and weak operating cash flow. Get the full

AthenaHealth Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.